BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 10219254)

  • 21. Transcription of AML1 in hematopoietic subfractions of normal adults.
    Bäsecke J; Feuring-Buske M; Brittinger G; Schaefer UW; Hiddemann W; Griesinger F
    Ann Hematol; 2002 May; 81(5):254-7. PubMed ID: 12029534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of AML/Runx and ETO/MTG family members during hematopoietic differentiation of embryonic stem cells.
    Okumura AJ; Peterson LF; Lo MC; Zhang DE
    Exp Hematol; 2007 Jun; 35(6):978-88. PubMed ID: 17533052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leukaemia -- a developmental perspective.
    Izraeli S
    Br J Haematol; 2004 Jul; 126(1):3-10. PubMed ID: 15198727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AlphaIIb integrin expression during development of the murine hemopoietic system.
    Corbel C; Salaün J
    Dev Biol; 2002 Mar; 243(2):301-11. PubMed ID: 11884039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Core binding factor genes and human leukemia.
    Hart SM; Foroni L
    Haematologica; 2002 Dec; 87(12):1307-23. PubMed ID: 12495904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cbfa2 is required for the formation of intra-aortic hematopoietic clusters.
    North T; Gu TL; Stacy T; Wang Q; Howard L; Binder M; Marín-Padilla M; Speck NA
    Development; 1999 Jun; 126(11):2563-75. PubMed ID: 10226014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early lineage priming by trisomy of Erg leads to myeloproliferation in a Down syndrome model.
    Ng AP; Hu Y; Metcalf D; Hyland CD; Ierino H; Phipson B; Wu D; Baldwin TM; Kauppi M; Kiu H; Di Rago L; Hilton DJ; Smyth GK; Alexander WS
    PLoS Genet; 2015 May; 11(5):e1005211. PubMed ID: 25973911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The neuropathology of the trisomy 16 mouse.
    Lacey-Casem ML; Oster-Granite ML
    Crit Rev Neurobiol; 1994; 8(4):293-322. PubMed ID: 7850875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Core binding factor and its role in normal hematopoietic development.
    Speck NA
    Curr Opin Hematol; 2001 Jul; 8(4):192-6. PubMed ID: 11561154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CBFA2, frequently rearranged in leukemia, is not responsible for a familial leukemia syndrome.
    Legare RD; Lu D; Gallagher M; Ho C; Tan X; Barker G; Shimizu K; Ohki M; Lenny N; Hiebert S; Gilliland DG
    Leukemia; 1997 Dec; 11(12):2111-9. PubMed ID: 9447828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Restoration of DSCR1 to disomy in the trisomy 16 mouse model of Down syndrome does not correct cardiac or craniofacial development anomalies.
    Lange AW; Rothermel BA; Yutzey KE
    Dev Dyn; 2005 Jul; 233(3):954-63. PubMed ID: 15906378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Redox regulation of neuronal migration in a Down Syndrome model.
    Behar TN; Colton CA
    Free Radic Biol Med; 2003 Sep; 35(6):566-75. PubMed ID: 12957649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased expression of voltage-activated calcium channels in cultured hippocampal neurons from mouse trisomy 16, a model for Down syndrome.
    Galdzicki Z; Coan EJ; Rapoport SI; Stoll J
    Brain Res Mol Brain Res; 1998 May; 56(1-2):200-6. PubMed ID: 9602127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of increased levels of class I MHC H-2Kk in the placenta of murine trisomy 16 conceptuses with structural abnormalities revealed by magnetic resonance microscopy.
    Kornguth S; Bersu E; Anderson M; Markley J
    Teratology; 1992 Apr; 45(4):383-91. PubMed ID: 1533959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stem cell deficiencies and thymic abnormalities in fetal mouse trisomy 16.
    Epstein CJ; Hofmeister BG; Yee D; Smith SA; Philip R; Cox DR; Epstein LB
    J Exp Med; 1985 Aug; 162(2):695-712. PubMed ID: 3160808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absence of fetal liver hematopoiesis in mice deficient in transcriptional coactivator core binding factor beta.
    Sasaki K; Yagi H; Bronson RT; Tominaga K; Matsunashi T; Deguchi K; Tani Y; Kishimoto T; Komori T
    Proc Natl Acad Sci U S A; 1996 Oct; 93(22):12359-63. PubMed ID: 8901586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Partial IFN-alpha/beta and IFN-gamma receptor knockout trisomy 16 mouse fetuses show improved growth and cultured neuron viability.
    Maroun LE; Heffernan TN; Hallam DM
    J Interferon Cytokine Res; 2000 Feb; 20(2):197-203. PubMed ID: 10714556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deficient transformation of murine trisomy 16 fetal liver cells by the Abelson and J2 viruses.
    Berger CN; Epstein CJ
    Immunol Lett; 1992 Jun; 33(1):47-51. PubMed ID: 1427990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue-specific overexpression of the HSA21 gene GABPalpha: implications for DS.
    O'Leary DA; Pritchard MA; Xu D; Kola I; Hertzog PJ; Ristevski S
    Biochim Biophys Acta; 2004 Dec; 1739(1):81-7. PubMed ID: 15607120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The genome-wide impact of trisomy 21 on DNA methylation and its implications for hematopoiesis.
    Muskens IS; Li S; Jackson T; Elliot N; Hansen HM; Myint SS; Pandey P; Schraw JM; Roy R; Anguiano J; Goudevenou K; Siegmund KD; Lupo PJ; de Bruijn MFTR; Walsh KM; Vyas P; Ma X; Roy A; Roberts I; Wiemels JL; de Smith AJ
    Nat Commun; 2021 Feb; 12(1):821. PubMed ID: 33547282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.